0001564590-21-046764.txt : 20210901 0001564590-21-046764.hdr.sgml : 20210901 20210901170620 ACCESSION NUMBER: 0001564590-21-046764 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210901 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210901 DATE AS OF CHANGE: 20210901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NUVASIVE INC CENTRAL INDEX KEY: 0001142596 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330768598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50744 FILM NUMBER: 211230930 BUSINESS ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 909-1800 MAIL ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 nuva-8k_20210901.htm 8-K nuva-8k_20210901.htm
false 0001142596 0001142596 2021-09-01 2021-09-01

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 1, 2021

 

NuVasive, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

000-50744

33-0768598

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

 

 

 

7475 Lusk Boulevard, San Diego, California 92121

(Address of principal executive offices) (Zip Code)

 

 

 

(858) 909-1800

(Registrant’s telephone number, including area code)

 

 

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

NUVA

The NASDAQ Stock Market LLC

(NASDAQ Global Select Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 

Item 8.01

Other Events.

 

On September 1, 2021, NuVasive, Inc. (the “Company”) issued a press release (the “Organizational Press Release”) announcing new executive leadership roles. A copy of the Organizational Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In the Organizational Press Release, the Company announced that it was realigning the leadership structure for its commercial, commercial enablement, product marketing, and spine research and development organizations, as well as NuVasive Specialized Orthopedics and NuVasive Clinical Services, effective September 1, 2021. Massimo Calafiore, who currently serves as Executive Vice President, Global Business Units, with responsibility for the Company’s business units, product marketing, and spine research and development functions, has assumed the role of Executive Vice President, Chief Commercial Officer, with responsibility for the Company’s product marketing, commercial, and commercial enablement functions, as well as the Company’s business units. The Company also announced that it created a new Chief Technology Officer role, reporting directly to the Chief Executive Officer, to lead spine research and development. With this new structure, the Company eliminated the role of Executive Vice President, Global Commercial, currently held by Brent Boucher, who will be transitioning out of the organization.

 

Item 9.01

Financial Statements and Exhibits.

 

 

(d)

Exhibits.

 

 

Exhibit No.

Description.

99.1

Press Release issued by NuVasive, Inc. on September 1, 2021

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

NUVASIVE, INC.

 

 

 

Date: September 1, 2021

 

/s/ Matthew K. Harbaugh

 

 

Matthew K. Harbaugh

 

 

Executive Vice President and Chief Financial Officer

 

EX-99.1 2 nuva-ex991_6.htm EX-99.1 nuva-ex991_6.htm

Exhibit 99.1

 

NEWS RELEASE

 

NuVasive Announces New Executive Leadership Roles

 

-- New roles strengthen innovation and go-to-market execution --

-- Massimo Calafiore appointed Chief Commercial Officer --

-- Ryan Donahoe appointed Chief Technology Officer --

 

SAN DIEGO September 1, 2021 – NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced new executive leadership roles, strengthening its innovation and go-to-market teams while furthering the Company’s growth. Effective immediately, Massimo Calafiore has been appointed Chief Commercial Officer, and Ryan Donahoe has been appointed Chief Technology Officer, both reporting directly to Chief Executive Officer J. Christopher Barry.

 

“This new structure puts in place leaders who have decades of spine and orthopedics experience to advance our near- and long-term strategy as we continue to globalize and scale our business,” said Mr. Barry. “I am confident Massimo’s and Ryan’s proven track records of building strong, effective teams and their commitment to our vision will help us deliver the strongest innovation pipeline in spine and increase value for our stakeholders.”

 

As Chief Commercial Officer, Massimo Calafiore will oversee the product marketing, commercial, and commercial enablement functions, as well as NuVasive Specialized Orthopedics and NuVasive Clinical Services. Since joining the Company in 2017, Mr. Calafiore has held various leadership roles with increasing levels of responsibility, most recently serving as executive vice president, Global Business Units. Prior to NuVasive, he spent 16 years supporting and leading the U.S. business for Waldemar Link, a leader in the orthopedics and medical device industry.

 

As Chief Technology Officer, Ryan Donahoe will continue to lead spine research and development. During his 15 years at NuVasive, Mr. Donahoe has played an integral role in shaping the Company’s comprehensive, procedurally integrated spine portfolio with more than 20 issued and pending patents. Through his leadership and partnership with surgeons, he has helped develop technologies throughout NuVasive’s anterior, posterior, and cervical procedural offerings, along with the integration of the Pulse platform.

 

In connection with this new leadership structure, Brent Boucher, executive vice president, Global Commercial, will transition from the Company.

 

About NuVasive

NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,700 employees and operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit www.nuvasive.com.


Forward-Looking Statements

NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange CommissionNuVasive's public filings with the Securities and Exchange Commission are available at www.sec.govNuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

###

 

Investor contact:

Juliet C. Cunningham

NuVasive, Inc.

858-210-2129

investorrelations@nuvasive.com  

 

Media contact:

Amanda Rocha

NuVasive, Inc.

858-882-5062

media@nuvasive.com

 

 

GRAPHIC 3 g3aeox1ak3w1000001.jpg GRAPHIC begin 644 g3aeox1ak3w1000001.jpg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�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end EX-101.SCH 4 nuva-20210901.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 5 nuva-20210901_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer EX-101.PRE 6 nuva-20210901_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 nuva-8k_20210901_htm.xml IDEA: XBRL DOCUMENT 0001142596 2021-09-01 2021-09-01 false 0001142596 8-K 2021-09-01 NuVasive, Inc. DE 000-50744 33-0768598 7475 Lusk Boulevard San Diego CA 92121 858 909-1800 false false false false Common Stock, par value $0.001 per share NUVA NASDAQ false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Sep. 01, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 01, 2021
Entity Registrant Name NuVasive, Inc.
Entity Central Index Key 0001142596
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol NUVA
Security Exchange Name NASDAQ
Entity File Number 000-50744
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 33-0768598
Entity Address, Address Line One 7475 Lusk Boulevard
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 909-1800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports nuva-8k_20210901.htm nuva-20210901.xsd nuva-20210901_lab.xml nuva-20210901_pre.xml nuva-ex991_6.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nuva-8k_20210901.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "nuva-8k_20210901.htm" ] }, "labelLink": { "local": [ "nuva-20210901_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "nuva-20210901_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "nuva-20210901.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nuva", "nsuri": "http://www.nuvasive.com/20210901", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "nuva-8k_20210901.htm", "contextRef": "C_0001142596_20210901_20210901", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "nuva-8k_20210901.htm", "contextRef": "C_0001142596_20210901_20210901", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20210901/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001564590-21-046764-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-046764-xbrl.zip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